Critical review of high-sensitivity C-reactive protein and coronary artery calcium for the guidance of statin allocation: head-to-head comparison of the JUPITER and St. Francis Heart Trials

Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):315-22. doi: 10.1161/CIRCOUTCOMES.113.000519. Epub 2014 Mar 11.

Authors

Joonseok Kim¹, John W McEvoy, Khurram Nasir, Matthew J Budoff, Yadon Arad, Roger S Blumenthal, Michael J Blaha

Affiliation

¹ Department of Medicine, Michigan State University, East Lansing, MI.

PMID: 24619319
DOI: 10.1161/CIRCOUTCOMES.113.000519

No abstract available

Keywords: C-reactive protein; atherosclerosis; biomarkers; cardiovascular diseases; coronary disease; statins, HMG-CoA.

Publication types

Comparative Study
Randomized Controlled Trial

MeSH terms

Aged
Aged, 80 and over
Atherosclerosis / diagnosis*
Atherosclerosis / drug therapy
Biomarkers / metabolism
C-Reactive Protein / metabolism*
Calcium / metabolism*
Coronary Vessels / metabolism
Cost-Benefit Analysis
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Male
Middle Aged
Practice Guidelines as Topic
Predictive Value of Tests
Primary Prevention
Prognosis
Sensitivity and Specificity
Treatment Outcome

Substances

Biomarkers
Hydroxymethylglutaryl-CoA Reductase Inhibitors
C-Reactive Protein
Calcium